Biomarkers of endocannabinoid system activation in severe obesity.
<h4>Background</h4>Obesity is a worldwide epidemic, and severe obesity is a risk factor for many diseases, including diabetes, heart disease, stroke, and some cancers. Endocannabinoid system (ECS) signaling in the brain and peripheral tissues is activated in obesity and plays a role in t...
Guardado en:
Autores principales: | Jack C Sipe, T Michael Scott, Sarah Murray, Olivier Harismendy, Gabriel M Simon, Benjamin F Cravatt, Jill Waalen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d5f7a287e3b8456095f9e6dec8c459a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Endocannabinoids measurement in human saliva as potential biomarker of obesity.
por: Isabelle Matias, et al.
Publicado: (2012) -
Endocannabinoids as potential biomarkers: It‘s all about pre-analytics
por: Daniel Kratz, et al.
Publicado: (2021) -
Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.
por: John M McPartland, et al.
Publicado: (2014) -
The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies
por: Robert Ramer, et al.
Publicado: (2021) -
Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system
por: Grégoire Chevalier, et al.
Publicado: (2020)